A rare mutation [IVS-I-130 (G-A)] in a Turkish beta-thalassemia major patient

G O Tadmouri1, O Bilenoğlu, S Kantarci

  • 1Department of Molecular Biology, Boğaziçi University, Bebek, Istanbul, Turkey.

Insights

The rare beta-thalassemia mutation IVS-I-130 (G-A) was identified in Turkey. Genetic analysis suggests a Northeastern African origin, likely introduced from Egypt in the late 19th century.

Area of Science:

  • Medical Genetics
  • Molecular Biology
  • Hematology

Background:

  • Beta-thalassemia is a significant inherited blood disorder.
  • Identifying rare mutations is crucial for understanding disease prevalence and origins.
  • The IVS-I-130 (G-A) mutation is a rare cause of beta-thalassemia.

Observation:

  • A patient in Turkey presented with classical signs of beta-thalassemia major.
  • DNA analysis revealed heterozygosity for IVS-I-6 (T-C) and the novel IVS-I-130 (G-A) mutations.
  • Haplotype analysis of the patient and family was performed using DNA sequencing.

Findings:

  • The IVS-I-130 (G-A) mutation was identified for the first time in Turkey.
  • The genetic haplotype (HT4) associated with the IVS-I-130 (G-A) mutation is also found in Algeria.
  • This points to a Northeastern African origin for the IVS-I-130 (G-A) mutation.

Implications:

  • The findings suggest a recent introduction of this beta-thalassemia mutation into Turkey from Egypt.
  • Understanding mutation origins aids in tracing population genetics and disease spread.
  • This research contributes to the genetic mapping of beta-thalassemia in the region.

Related Concept Videos

Mutations01:39

Mutations

Overview
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Mutations01:39

Mutations

Overview
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...